<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>3</IssueIDStart>
          <IssueIDEnd>3</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>9</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art7">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>73566</ArticleID>
            <ArticleDOI>10.1208/aapsj070357</ArticleDOI>
            <ArticleSequenceNumber>7</ArticleSequenceNumber>
            <ArticleTitle Language="En">Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs</ArticleTitle>
            <ArticleFirstPage>E566</ArticleFirstPage>
            <ArticleLastPage>E571</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>2</Month>
                <Day>4</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>7</Month>
                <Day>29</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>3</IssueIDStart>
              <IssueIDEnd>3</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1 Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Valeria</GivenName>
                  <FamilyName>Alcon</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Maria</GivenName>
                  <FamilyName>Baca-Estrada</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Marco</GivenName>
                  <FamilyName>Vega-Lopez</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Philip</GivenName>
                  <FamilyName>Willson</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Lorne</GivenName>
                  <GivenName>A.</GivenName>
                  <FamilyName>Babiuk</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff3">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Praveen</GivenName>
                  <FamilyName>Kumar</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff4">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Rolf</GivenName>
                  <FamilyName>Hecker</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Marianna</GivenName>
                  <FamilyName>Foldvari</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(306) 966-6338</Phone>
                  <Fax>(306) 966-6377</Fax>
                  <Email>foldvari@duke.usask.ca</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Department of Pharmaceutics/Pharmacy, College of Pharmacy and Nutrition</OrgDivision>
                <OrgName>University of Saskatchewan</OrgName>
                <OrgAddress>
                  <Street>110 Science Place</Street>
                  <Postcode>S7N 5C9</Postcode>
                  <City>Saskatoon</City>
                  <State>Saskatchewan</State>
                  <Country>Canada</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgName>Vaccine and Infectious Disease Organization</OrgName>
                <OrgAddress>
                  <City>Saskatoon</City>
                  <State>SK</State>
                  <Country>Canada</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff3">
                <OrgName>PharmaDerm Laboratories Ltd</OrgName>
                <OrgAddress>
                  <Street>Innovation Place Research Park</Street>
                  <City>Saskatoon</City>
                  <State>SK</State>
                  <Country>Canada</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff4">
                <OrgName>QIAGEN GmbH</OrgName>
                <OrgAddress>
                  <City>Hilden</City>
                  <Country>Germany</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>The ineffectiveness of simple delivery of soluble antigens to mucosal membranes for immunization has stimulated extensive studies of strategies for appropriate delivery systems and adjuvants. Biphasic lipid vesicles are formulations suitable for the delivery of proteins, peptides, and oligo/polynucleotides. The purpose of these studies was to investigate the ability of biphasic lipid vesicles (as vaccinetargeting adjuvants) containing a bacterial antigen and unmethylated oligonucleotides containing CGdinucleotides-CpG motifs (CpG ODNs) to induce systemic and mucosal immune responses in pigs. Results showed that while the protein, either alone or with CpG ODNs, did not induce mucosal immune responses, administration of antigen and CpG ODNs in biphasic lipid vesicles resulted in induction of boty systemic and local antibody responses after immunization using a combined mucosal/systemic approach.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>Mucosal immunity</Keyword>
              <Keyword>biphasic lipid delivery systems</Keyword>
              <Keyword>CpG ODNs</Keyword>
              <Keyword>porcine</Keyword>
              <Keyword>Actinobacillus pleuropneumoniae</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 14, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_73566.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>NP</Initials>
                    <FamilyName>Goonetilleke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>McShane</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Hannan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RH</Initials>
                    <FamilyName>Brookes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AV</Initials>
                    <FamilyName>Hill</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modofied vaccinia virus Ankara</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>171</VolumeID>
                  <FirstPage>1602</FirstPage>
                  <LastPage>1609</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12874255</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXlsFyksr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH, Hill AV. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modofied vaccinia virus Ankara.<Emphasis Type="Italic">J Immunol</Emphasis>. 2003;171:1602–1609.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Kaul</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PL</Initials>
                    <FamilyName>Ogra</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Mucosal resonses to parenteral and mucosal vaccines</ArticleTitle>
                  <JournalTitle>Dev Biol Stand.</JournalTitle>
                  <VolumeID>95</VolumeID>
                  <FirstPage>141</FirstPage>
                  <LastPage>146</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9855424</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1M%2FntFSltA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kaul D, Ogra PL. Mucosal resonses to parenteral and mucosal vaccines.<Emphasis Type="Italic">Dev Biol Stand.</Emphasis> 1998;95:141–146.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>XS</Initials>
                    <FamilyName>Liu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Abdul-Jabbar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YM</Initials>
                    <FamilyName>Qi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IH</Initials>
                    <FamilyName>Frazer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zhou</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice</ArticleTitle>
                  <JournalTitle>Virology</JournalTitle>
                  <VolumeID>252</VolumeID>
                  <FirstPage>39</FirstPage>
                  <LastPage>45</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9875315</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/viro.1998.9442</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXotFSitLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liu XS, Abdul-Jabbar I, Qi YM, Frazer IH, Zhou J. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.<Emphasis Type="Italic">Virology</Emphasis>. 1998;252:39–45.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>McCluskie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Weeratna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Payette</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HL</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA</ArticleTitle>
                  <JournalTitle>FEMS Immunol Med Microbiol</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>179</FirstPage>
                  <LastPage>185</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11934561</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1574-695X.2002.tb00551.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XisV2mu7Y%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McCluskie MJ, Weeratna RD, Payette PJ, Davis HL. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.<Emphasis Type="Italic">FEMS Immunol Med Microbiol</Emphasis>. 2002;32:179–185.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>McGhee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Mestecky</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MT</Initials>
                    <FamilyName>Dertzbaugh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JH</Initials>
                    <FamilyName>Eldridge</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hirasawa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kiyono</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">The mucosal immune system: from fundamental concepts to vaccine development</ArticleTitle>
                  <JournalTitle>Vaccine</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>75</FirstPage>
                  <LastPage>88</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1539467</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0264-410X(92)90021-B</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:By2C2s%2FitFw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development.<Emphasis Type="Italic">Vaccine</Emphasis>. 1992;10:75–88.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Liljeqvist</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Stahl</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines</ArticleTitle>
                  <JournalTitle>J Biotechnol</JournalTitle>
                  <VolumeID>73</VolumeID>
                  <FirstPage>1</FirstPage>
                  <LastPage>33</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10483112</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0168-1656(99)00107-8</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXmtFGisL4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Liljeqvist S, Stahl S. Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines.<Emphasis Type="Italic">J Biotechnol</Emphasis>. 1999;73:1–33.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Rappuoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Pizza</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Douce</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Dougan</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins</ArticleTitle>
                  <JournalTitle>Immunol Today</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>493</FirstPage>
                  <LastPage>500</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10529776</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0167-5699(99)01523-6</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXmvVKhsL4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rappuoli R, Pizza M, Douce G, Dougan G. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins.<Emphasis Type="Italic">Immunol Today</Emphasis>. 1999;20:493–500.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Takahashi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Marinaro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kiyono</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin</ArticleTitle>
                  <JournalTitle>J Infect Dis</JournalTitle>
                  <VolumeID>173</VolumeID>
                  <FirstPage>627</FirstPage>
                  <LastPage>635</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8627026</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhvVeqtrw%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1093/infdis/173.3.627</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Takahashi I, Marinaro M, Kiyono H, et al. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.<Emphasis Type="Italic">J Infect Dis</Emphasis>. 1996;173:627–635.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>NA</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TR</Initials>
                    <FamilyName>Hirst</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TO</Initials>
                    <FamilyName>Nashar</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic</ArticleTitle>
                  <JournalTitle>Immunol Today</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>95</FirstPage>
                  <LastPage>101</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10098329</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0167-5699(98)01397-8</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhvVWhs7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Williams NA, Hirst TR, Nashar TO. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic.<Emphasis Type="Italic">Immunol Today</Emphasis>. 1999;20:95–101.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>FW</Initials>
                    <FamilyName>Ginkel</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Jackson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Yuki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>McGhee</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>165</VolumeID>
                  <FirstPage>4778</FirstPage>
                  <LastPage>4782</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11045998</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.4049/jimmunol.165.9.4778</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>van Ginkel FW, Jackson RJ, Yuki Y, McGhee JR. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues.<Emphasis Type="Italic">J Immunol</Emphasis>. 2000;165:4778–4782.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Krieg</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Immune effects and mechanisms of action of CpG motifs</ArticleTitle>
                  <JournalTitle>Vaccine</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <FirstPage>618</FirstPage>
                  <LastPage>622</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11090712</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0264-410X(00)00249-8</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXot12lsLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Krieg AM. Immune effects and mechanisms of action of CpG motifs.<Emphasis Type="Italic">Vaccine</Emphasis>. 2000;19:618–622.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>McCluskie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HL</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">CpG DNA as mucosal adjuvant</ArticleTitle>
                  <JournalTitle>Vaccine</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>231</FirstPage>
                  <LastPage>237</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10506647</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0264-410X(99)00194-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXnsVegtbw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McCluskie MJ, Davis HL. CpG DNA as mucosal adjuvant.<Emphasis Type="Italic">Vaccine</Emphasis>. 1999;18:231–237.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Babiuk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Baca-Estrada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DM</Initials>
                    <FamilyName>Middleton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Hecker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Babiuk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Foldvari</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration</ArticleTitle>
                  <JournalTitle>Curr Drug Deliv</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>9</FirstPage>
                  <LastPage>15</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16305366</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1567201043479993</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXhsVSqu7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Babiuk S, Baca-Estrada ME, Middleton DM, Hecker R, Babiuk LA, Foldvari M. Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration.<Emphasis Type="Italic">Curr Drug Deliv</Emphasis>. 2004;1:9–15.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>VL</Initials>
                    <FamilyName>Alcon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Foldvari</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Snider</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery systems (Biphasix)</ArticleTitle>
                  <JournalTitle>Vaccine</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>1811</FirstPage>
                  <LastPage>1814</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12706664</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0264-410X(03)00003-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjtFWmtb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Alcon VL, Foldvari M, Snider M, et al. Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery systems (Biphasix).<Emphasis Type="Italic">Vaccine</Emphasis>. 2003;21:1811–1814.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GF</Initials>
                    <FamilyName>Gerlach</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Klashinsky</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Rossi-Campos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Potter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PJ</Initials>
                    <FamilyName>Willson</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1</ArticleTitle>
                  <JournalTitle>Infect Immun</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>565</FirstPage>
                  <LastPage>572</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8423086</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXit1yms70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gerlach GF, Anderson C, Klashinsky S, Rossi-Campos A, Potter AA, Willson PJ. Molecular characterization of a protective outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumoniae serotype 1.<Emphasis Type="Italic">Infect Immun</Emphasis>. 1993;61:565–572.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibUnstructured>Foldvari M, inventor. US patent 5 853 755. December 29, 1998.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibUnstructured>Foldvari M, Baca-Estrada ME, inventor. US patent 5 993 852. November 30, 1999.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Rankin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Pontarollo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Ioannou</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved</ArticleTitle>
                  <JournalTitle>Antisense Nucleic Acid Drug Dev.</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>333</FirstPage>
                  <LastPage>340</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11763350</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/108729001753231713</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXosVylsrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rankin R, Pontarollo R, Ioannou X, et al. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved.<Emphasis Type="Italic">Antisense Nucleic Acid Drug Dev.</Emphasis> 2001;11:333–340.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Foss</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MP</Initials>
                    <FamilyName>Murtaugh</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Mucosal immunogenicity and adjuvanticity of cholera toxin in swine</ArticleTitle>
                  <JournalTitle>Vaccine</JournalTitle>
                  <VolumeID>17</VolumeID>
                  <FirstPage>788</FirstPage>
                  <LastPage>801</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10067684</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0264-410X(98)00263-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXhs1CnsLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Foss DL, Murtaugh MP. Mucosal immunogenicity and adjuvanticity of cholera toxin in swine.<Emphasis Type="Italic">Vaccine</Emphasis>. 1999;17: 788–801.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AV</Initials>
                    <FamilyName>Capozzo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Cuberos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Levine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MF</Initials>
                    <FamilyName>Pasetti</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers</ArticleTitle>
                  <JournalTitle>Infect Immun.</JournalTitle>
                  <VolumeID>72</VolumeID>
                  <FirstPage>4637</FirstPage>
                  <LastPage>4646</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15271924</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1128/IAI.72.8.4637-4646.2004</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmtlyms7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Capozzo AV, Cuberos L, Levine MM, Pasetti MF. Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.<Emphasis Type="Italic">Infect Immun.</Emphasis> 2004;72:4637–4646.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Gockel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Bao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KW</Initials>
                    <FamilyName>Beagley</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract</ArticleTitle>
                  <JournalTitle>Mol Immunol</JournalTitle>
                  <VolumeID>37</VolumeID>
                  <FirstPage>537</FirstPage>
                  <LastPage>544</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11163403</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0161-5890(00)00074-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXitVyntA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gockel CM, Bao S, Beagley KW. Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract.<Emphasis Type="Italic">Mol Immunol</Emphasis>. 2000;37:537–544.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>DP</Initials>
                    <FamilyName>Snider</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins</ArticleTitle>
                  <JournalTitle>Crit Rev Immunol</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>317</FirstPage>
                  <LastPage>348</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8834454</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28Xhs1ygsrs%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1615/CritRevImmunol.v15.i3-4.70</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Snider DP. The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins.<Emphasis Type="Italic">Crit Rev Immunol</Emphasis>. 1995;15:317–348.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GM</Initials>
                    <FamilyName>Glenn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Scharton-Kersten</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Vassell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CP</Initials>
                    <FamilyName>Mallett</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TL</Initials>
                    <FamilyName>Hale</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CR</Initials>
                    <FamilyName>Alving</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>161</VolumeID>
                  <FirstPage>3211</FirstPage>
                  <LastPage>3214</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9759833</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmsFWntrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Glenn GM, Scharton-Kersten T, Vassell R, Mallett CP, Hale TL, Alving CR. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.<Emphasis Type="Italic">J Immunol</Emphasis>. 1998;161:3211–3214.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WS</Initials>
                    <FamilyName>Gallichan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RN</Initials>
                    <FamilyName>Woolstencroft</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Guarasci</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>McCluskie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HL</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Rosenthal</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract</ArticleTitle>
                  <JournalTitle>J Immunol</JournalTitle>
                  <VolumeID>166</VolumeID>
                  <FirstPage>3451</FirstPage>
                  <LastPage>3457</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11207303</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXhs1Ois7s%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.4049/jimmunol.166.5.3451</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Gallichan WS, Woolstencroft RN, Guarasci T, McCluskie MJ, Davis HL, Rosenthal KL. Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract.<Emphasis Type="Italic">J Immunol</Emphasis>. 2001;166:3451–3457.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>McCluskie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Weeratna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HL</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution</ArticleTitle>
                  <JournalTitle>Mol Med</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>867</FirstPage>
                  <LastPage>877</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11126201</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXot1WgtL8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McCluskie MJ, Weeratna RD, Davis HL. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.<Emphasis Type="Italic">Mol Med</Emphasis>. 2000;6:867–877.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MJ</Initials>
                    <FamilyName>McCluskie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>Weeratna</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HL</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants</ArticleTitle>
                  <JournalTitle>Vaccine</JournalTitle>
                  <VolumeID>19</VolumeID>
                  <FirstPage>2657</FirstPage>
                  <LastPage>2660</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11257405</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0264-410X(00)00496-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXitVOitrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McCluskie MJ, Weeratna RD, Davis HL. The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.<Emphasis Type="Italic">Vaccine</Emphasis>. 2001;19:2657–2660.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W</Initials>
                    <FamilyName>Olszewska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CD</Initials>
                    <FamilyName>Partidos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MW</Initials>
                    <FamilyName>Steward</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants</ArticleTitle>
                  <JournalTitle>Infect Immun</JournalTitle>
                  <VolumeID>68</VolumeID>
                  <FirstPage>4923</FirstPage>
                  <LastPage>4929</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10948106</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1128/IAI.68.9.4923-4929.2000</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXmtVelu78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Olszewska W, Partidos CD, Steward MW. Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants.<Emphasis Type="Italic">Infect Immun</Emphasis>. 2000;68:4923–4929.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Babiuk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ME</Initials>
                    <FamilyName>Baca-Estrada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Pontarollo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Foldvari</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix)</ArticleTitle>
                  <JournalTitle>J Pharm Pharmacol</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>1609</FirstPage>
                  <LastPage>1614</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12542889</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1211/002235702289</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXkvVWnsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Babiuk S, Baca-Estrada ME, Pontarollo R, Foldvari M. Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix).<Emphasis Type="Italic">J Pharm Pharmacol</Emphasis>. 2002;54:1609–1614.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Farman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DJ</Initials>
                    <FamilyName>Kornbrust</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Oligodeoxynucleotide studies in primates: antisense and immune stimulatory indications</ArticleTitle>
                  <JournalTitle>Toxicol Pathol</JournalTitle>
                  <VolumeID>31</VolumeID>
                  <FirstPage>119</FirstPage>
                  <LastPage>122</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12597439</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjtVelsbk%3D</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1080/01926230309779</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Farman CA, Kornbrust DJ. Oligodeoxynucleotide studies in primates: antisense and immune stimulatory indications.<Emphasis Type="Italic">Toxicol Pathol</Emphasis>. 2003;31:119–122.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SK</Initials>
                    <FamilyName>Klimuk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Semple</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PN</Initials>
                    <FamilyName>Nahimey</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther</JournalTitle>
                  <VolumeID>292</VolumeID>
                  <FirstPage>480</FirstPage>
                  <LastPage>488</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10640283</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXotFegtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Klimuk SK, Semple SC, Nahimey PN, et al. Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2000;292:480–488.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MC</Initials>
                    <FamilyName>Oliveira</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Boutet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Fattal</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice</ArticleTitle>
                  <JournalTitle>Life Sci</JournalTitle>
                  <VolumeID>67</VolumeID>
                  <FirstPage>1625</FirstPage>
                  <LastPage>1637</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10983856</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0024-3205(00)00745-1</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>De Oliveira MC, Boutet V, Fattal E, et al. Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice.<Emphasis Type="Italic">Life Sci</Emphasis>. 2000;67:1625–1637.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Murphy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DL</Initials>
                    <FamilyName>Nelson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PF</Initials>
                    <FamilyName>Wright</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>Tierney</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Phelan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RM</Initials>
                    <FamilyName>Chanock</FamilyName>
                  </BibAuthorName>
                  <Year>1982</Year>
                  <ArticleTitle Language="En">Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines</ArticleTitle>
                  <JournalTitle>Infect Immun</JournalTitle>
                  <VolumeID>36</VolumeID>
                  <FirstPage>1102</FirstPage>
                  <LastPage>1108</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7095844</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:Bi2B3sfhs1I%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Murphy BR, Nelson DL, Wright PF, Tierney EL, Phelan MA, Chanock RM. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.<Emphasis Type="Italic">Infect Immun</Emphasis>. 1982;36:1102–1108.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
